Business | Published:

Biochemist strikes gold

Naturevolume 441page689 (2006) | Download Citation

Subjects

Merck is tapping into academic research in its hunt for drug candidates. Meredith Wadman reports on the company's latest deal with Harvard.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    The Eye Diseases Prevalence Research Group Arch. Ophthalmol. 122, 564–572 (2004).

  2. 2

    Xue, L., Gollapalli, D. R., Maiti, P., Jahng, W. J. & Rando, R. R. Cell 117, 761–771 (2004).

  3. 3

    Gollapalli, D. R. & Rando, R. R. Proc. Natl Acad. Sci. USA 101, 10030–10035 (2004).

  4. 4

    Maiti, P., Gollapalli, D. & Rando, R. R. Biochemistry 44, 14463–14469 (2005).

  5. 5

    Maiti, P. et al. Biochemistry 45, 852–860 (2006).

Download references

Authors

  1. Search for Meredith Wadman in:

Related links

About this article

Publication history

Published

Issue Date

DOI

https://doi.org/10.1038/441689a

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.